Polycystic Kidney Disease Management
多囊肾病管理
Duration
Ongoing management with semi-annual reviews
Recovery
Chronic condition requiring lifelong monitoring
Savings
~85% vs US
Average savings compared to US prices
Comprehensive management program for autosomal dominant polycystic kidney disease (ADPKD) at specialized nephrology centers in China. Programs include genetic counseling, tolvaptan therapy initiation, cyst complication management, and long-term disease monitoring. China's large PKD patient population has driven expertise in both medical and surgical management approaches.
Comprehensive PKD Assessment
MRI volumetry, GFR measurement, genetic testing, and total kidney volume calculation for prognostication
Duration: 2-3 daysRisk Classification
Mayo classification staging to determine disease progression rate and treatment eligibility
Duration: 1 dayTherapy Initiation
Tolvaptan initiation with liver function monitoring, blood pressure optimization, and lifestyle counseling
Duration: 3-5 daysLong-Term Monitoring
Regular imaging, renal function tracking, complication management, and family screening coordination
Duration: Ongoing- Access to tolvaptan at significantly reduced cost
- Expert PKD specialists with large case volumes
- Comprehensive genetic counseling services
- Integrated management of hepatic and renal cysts
- Tolvaptan-associated liver toxicity requiring monitoring
- Polyuria and thirst from vasopressin antagonism
- Disease progression despite treatment
- Need for eventual renal replacement therapy
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.